Arcus outlines PEAK-1 full enrollment by year-end 2026 with cash runway into 2H 2028
Arcus Biosciences, Inc. · PHARMACEUTICAL PREPARATIONS · Now $25.34
-8.5% in 7d after detection
Post-detection moves
1h
—
1d
-4.7%
3d
-4.4%
7d
-8.5%
30d
—
Get alerts like this in real time
Push notifications the moment a signal fires. No spam, no crypto, no fluff.
Download for iOS